vimarsana.com

Page 40 - ஆரோக்கியம் அமைப்பு மருந்தாளுநர்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hospitals file lawsuit over drug companies refusal to give 340B discounts

Hospitals file lawsuit over drug companies refusal to give 340B discounts A growing number of drug companies have refused to provide discounts after an HHS decision to cut payments by 30% was upheld on appeal. , Managing Editor Five hospital groups and an organization of hospital pharmacists representing participants in the 340B drug pricing program, have filed a federal lawsuit against the U.S. Department of Health and Human Services over what they call the department s failure to enforce program requirements that require drug companies to provide prescription drug discounts under the 340B program. The groups also submitted a memo in support of a permanent injunction against current drug company practices.   

AHA, others file lawsuit over drug companies refusing 340B discounts

Dec 14, 2020 - 03:18 PM The AHA, joined by four other national hospital groups and hospital pharmacists representing participants in the 340B drug pricing program, Friday filed a federal lawsuit against the Department of Health and Human Services over the department’s failure to enforce program requirements and halt drug company actions that undermine the program. The groups are joined in the lawsuit by three 340B hospitals serving patient communities in need that have been harmed by the companies’ refusals to provide discounts on prescription drugs dispensed at community-based pharmacies, as required by the 340B program. “The 340B program plays a critical role in helping eligible hospitals provide a wide range of comprehensive services and low-cost drugs to vulnerable patients and communities, many of which have been the hardest hit by the COVID-19 pandemic,” said AHA President and CEO Rick Pollack. “This lawsuit will require the department to take actions that we’v

Pfizer, BioNTech COVID-19 vaccine gets emergency use authorization

Managing Editor The first vaccine to prevent COVID-19 has been cleared for use in the United States. The Food and Drug Administration on Saturday granted emergency use authorization to Pfizer and BioNTech’s COVID-19 vaccine for use in individuals 16 years old and older. The first shipments began leaving facilities on Sunday.  The FDA’s decision was based on data from its Phase 3 clinical study, whose results were published last week in the New England Journal of Medicine and which saw a 95% vaccine efficacy rate. The two companies continue to gather additional data and prepare a biologics license application for full approval from the FDA in 2021. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.